
DexCom DXCM
$ 63.06
-1.5%
Annual report 2025
added 02-12-2026
DexCom EV/EBITDA Ratio 2011-2026 | DXCM
Annual EV/EBITDA Ratio DexCom
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 39.5 | 98.4 | 117 | -79.8 | -190 | -132 | -121 | -338 | -126 | -21 | -17.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 | -338 | -70 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.14 | 0.44 % | $ 6.21 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 16.07 | 1.39 % | $ 173 M | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
27.4 | $ 115.09 | 0.03 % | $ 35 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.25 | -2.17 % | $ 9.95 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 16.32 | 1.65 % | $ 870 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 498.22 | 0.95 % | $ 14.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.45 | 2.3 % | $ 412 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 7.87 | 2.34 % | $ 1.01 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.4 | 2.19 % | $ 1.86 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 23.05 | -0.35 % | $ 640 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.62 | -0.9 % | $ 276 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 176.51 | 0.49 % | $ 8.75 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 52.58 | -0.1 % | $ 2.67 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 190.99 | 0.73 % | $ 136 B | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.37 | 1.11 % | $ 90.4 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
70.5 | $ 122.69 | 1.46 % | $ 19.5 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 14.96 | 3.67 % | $ 452 M | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 500.25 | 0.83 % | $ 189 B | ||
|
Trinity Biotech plc
TRIB
|
12.6 | $ 0.69 | -3.28 % | $ 61.9 M | ||
|
Guardant Health
GH
|
-28.8 | $ 79.27 | 0.85 % | $ 9.94 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 48.44 | 1.11 % | $ 2.9 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.73 | 1.49 % | $ 88.6 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.1 | -2.1 % | $ 4.82 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 28.26 | -0.18 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 107.45 | 0.59 % | $ 8.86 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 261.12 | 0.07 % | $ 21.7 B | ||
|
Natera
NTRA
|
-19.5 | $ 197.55 | 2.34 % | $ 19.4 B | ||
|
Celcuity
CELC
|
-2.38 | $ 118.08 | 0.8 % | $ 5.52 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 80.41 | -0.23 % | $ 5.43 B | ||
|
Waters Corporation
WAT
|
24.6 | $ 318.26 | -0.54 % | $ 19 B |